whether EVERY patient with type 2 diabetes should get an ACE inhibitor or ARB, aspirin, and statin

November 2012

You'll hear controversy over whether EVERY patient with type 2 diabetes should get an ACE inhibitor or ARB, aspirin, and statin.

This push is partly due to insurer pay-for-performance programs. And even though these drugs are often helpful, watch for the exceptions.

ACEIs/ARBs. Continue to use an ACEI or ARB for diabetes patients with hypertension...to improve cardiovascular and renal outcomes.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote